TRACON Pharmaceuticals, Inc. - stock earnings
TCON Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 439000 USD | 3.0 million USD |
| 2023Q3 | 10.8 million USD | ? USD |
| 2023Q2 | -6.3 million USD | 9.0 million USD |
| 2023Q1 | -10.9 million USD | ? USD |
| 2022Q4 | -7.2 million USD | ? USD |
| 2022Q3 | -6.5 million USD | ? USD |
| 2022Q2 | -6.2 million USD | ? USD |
| 2022Q1 | -9.5 million USD | ? USD |
| 2021Q4 | -7.7 million USD | -346000 USD |
| 2021Q3 | -7.0 million USD | ? USD |
| 2021Q2 | -8.9 million USD | 346000 USD |
| 2021Q1 | -5.1 million USD | ? USD |
| 2020Q4 | -4.3 million USD | ? USD |
| 2020Q3 | -4.0 million USD | ? USD |
| 2020Q2 | -4.5 million USD | ? USD |
| 2020Q1 | -4.0 million USD | ? USD |
| 2019Q4 | -3.9 million USD | ? USD |
| 2019Q3 | -5.2 million USD | ? USD |
| 2019Q2 | -6.3 million USD | ? USD |
| 2019Q1 | -7.2 million USD | ? USD |
| 2018Q4 | -7.8 million USD | 3.0 million USD |
| 2018Q3 | -9.1 million USD | ? USD |
| 2018Q2 | -9.8 million USD | 3.0 million USD |
| 2018Q1 | -8.4 million USD | 3.0 million USD |
| 2017Q4 | -6.6 million USD | 1.3 million USD |
| 2017Q3 | 1.2 million USD | 7.5 million USD |
| 2017Q2 | -6.6 million USD | 631000 USD |
| 2017Q1 | -7.1 million USD | 626000 USD |
| 2016Q4 | -6.3 million USD | 617000 USD |
| 2016Q3 | -5.9 million USD | 815000 USD |
| 2016Q2 | -8.3 million USD | 807000 USD |
| 2016Q1 | -6.5 million USD | 1.2 million USD |
| 2015Q4 | -11.0 million USD | 1.4 million USD |
| 2015Q3 | -6.4 million USD | 1.2 million USD |
| 2015Q2 | -2.9 million USD | 4.2 million USD |
| 2015Q1 | -4.0 million USD | 1.1 million USD |
| 2014Q4 | -2.5 million USD | 1.0 million USD |
| 2014Q3 | -1.9 million USD | 1.1 million USD |
| 2014Q2 | -980000 USD | 1.1 million USD |
| 2014Q1 | -1.4 million USD | 356000 USD |
| 2013Q4 | -2.2 million USD | ? USD |
TCON Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -3.6 million USD | 12.0 million USD |
| 2022 | -29.3 million USD | 9.0 million USD |
| 2021 | -28.7 million USD | 346000 USD |
| 2020 | -17.3 million USD | 346000 USD |
| 2019 | -22.7 million USD | ? USD |
| 2018 | -35.0 million USD | 3.0 million USD |
| 2017 | -19.1 million USD | 8.8 million USD |
| 2016 | -27.0 million USD | 3.4 million USD |
| 2015 | -24.4 million USD | 7.9 million USD |
| 2014 | -6.8 million USD | 3.6 million USD |
| 2013 | -7.7 million USD | ? USD |
| 2012 | -4.9 million USD | ? USD |
TCON
Price: $1.90
52 week price:
Earnings Per Share: -2.20 USD
P/E Ratio: -0.45
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 47100
Ebitda: 1.4 millionMarket Capitalization: 5.4 million